284 related articles for article (PubMed ID: 23021713)
21. Laparoscopy in the management of peritoneal carcinomatosis.
Garofalo A; Valle M
Cancer J; 2009; 15(3):190-5. PubMed ID: 19556903
[TBL] [Abstract][Full Text] [Related]
22. Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.
Helm CW
Surg Oncol Clin N Am; 2012 Oct; 21(4):645-63. PubMed ID: 23021722
[TBL] [Abstract][Full Text] [Related]
23. [Resectional treatment of peritoneal carcinomatosis followed by intraperitoneal chemotherapy, practical aspects].
Elias D; Lasser P; Reynard B; Ducreux M; Pocard M
J Chir (Paris); 2003 Oct; 140(5):270-6. PubMed ID: 14631291
[TBL] [Abstract][Full Text] [Related]
24. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Baratti D; Vaira M; Kusamura S; D'Amico S; Balestra MR; Cioppa T; Mingrone E; De Simone M; Deraco M
Eur J Surg Oncol; 2010 Nov; 36(11):1047-53. PubMed ID: 20832234
[TBL] [Abstract][Full Text] [Related]
25. Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy.
Van der Speeten K; Stuart OA; Sugarbaker PH
Surg Oncol Clin N Am; 2012 Oct; 21(4):577-97. PubMed ID: 23021717
[TBL] [Abstract][Full Text] [Related]
26. Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve.
Mohamed F; Moran BJ
Cancer J; 2009; 15(3):196-9. PubMed ID: 19556904
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
Cashin PH; Graf W; Nygren P; Mahteme H
Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Roviello F; Caruso S; Marrelli D; Pedrazzani C; Neri A; De Stefano A; Pinto E
G Chir; 2011 Apr; 32(4):211-33. PubMed ID: 21554854
[TBL] [Abstract][Full Text] [Related]
29. [Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy].
Kavanagh M; Ouellet JF;
Bull Cancer; 2006 Sep; 93(9):867-74. PubMed ID: 16980229
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.
Facchiano E; Scaringi S; Kianmanesh R; Sabate JM; Castel B; Flamant Y; Coffin B; Msika S
Eur J Surg Oncol; 2008 Feb; 34(2):154-8. PubMed ID: 17640844
[TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions.
Stewart JH; Shen P; Levine EA
Ann Surg Oncol; 2005 Oct; 12(10):765-77. PubMed ID: 16132375
[TBL] [Abstract][Full Text] [Related]
32. Analysis of operative morbidity in a single center initial experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Graziosi L; Mingrone E; Marino E; Cavazzoni E; Donini A
Tumori; 2014; 100(1):15-20. PubMed ID: 24675485
[TBL] [Abstract][Full Text] [Related]
33. Use of hyperthermic intraperitoneal chemotherapy (HIPEC) in management of peritoneal carcinomatosis from colorectal origin.
Ceelen WP
Surg Technol Int; 2005; 14():125-30. PubMed ID: 16525964
[TBL] [Abstract][Full Text] [Related]
34. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
[TBL] [Abstract][Full Text] [Related]
35. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
[TBL] [Abstract][Full Text] [Related]
36. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
38. Results of cytoreduction followed by HIPEC in carcinomatosis of colorectal origin.
Verwaal VJ
Cancer Treat Res; 2007; 134():291-301. PubMed ID: 17633061
[No Abstract] [Full Text] [Related]
39. Patient selection for a curative approach to carcinomatosis.
Piso P; Glockzin G; von Breitenbuch P; Sulaiman T; Popp F; Dahlke M; Esquivel J; Schlitt HJ
Cancer J; 2009; 15(3):236-42. PubMed ID: 19556910
[TBL] [Abstract][Full Text] [Related]
40. The role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC).
Sommariva A; Zagonel V; Rossi CR
Ann Surg Oncol; 2012 Nov; 19(12):3737-44. PubMed ID: 22805859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
